Ardos

1. 08 May 2026

   Unknown

   —

   Cumulative —

Amounts in EUR, converted at the ECB rate on the event date. Funding totals exclude debt, grants and state aid; rounds whose instrument is not yet established are still counted. Every figure links to its source.

• Funding08 May 2026

  Ardos has raised investment from Delphinus Venture Capital for its software platform DoseTracker, aimed at improving cancer treatment precision.

  ▸Source: TechSavvy.media

  “Medtech-startuppet Ardos fra Aarhus vil ændre en af de mest grundlæggende usikkerheder i moderne kræftbehandling. Nemlig om patienten faktisk modtager den strålingsdosis, lægerne planlægger. Ardos er…”

  Read at TechSavvy.media

• Lene Ploug Bülow

  working chairperson and co-owner

• Per Poulsen

  Chief Scientific Officer and Co-Founder

• Thomas Ravkilde

  CEO and Founder

What does Ardos do?

Medtech startup focused on real-time radiation dose verification during cancer treatment.

When was Ardos founded?

Ardos was founded in 2022.

Where is Ardos headquartered?

Ardos is based in Denmark.

What was Ardos's latest funding round?

Ardos's most recent disclosed round was a unknown round, announced 8 May 2026.

Who has invested in Ardos?

Investors in Ardos include Delphinus Venture Capital.